IN Ketamine Vs IN Midazolam and Fentanyl for Abscess I&D

• Status: Completed
• Trial end date: 2017-03-23
• Target enrollment: 0
• Participant gender: All

Summary

The general objective of this study is to determine whether intranasal ketamine should be incorporated into formulary as an option to treat pain during minor procedures in the pediatric emergency department.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Tennessee Health Science Center
• Treatments: Fentanyl; Ketamine; Midazolam

Criteria

Inclusion Criteria:

• Diagnosis of abscess with planned incision and drainage of a single abscess

Exclusion Criteria:

• Fast Track patients

• Patients who have received an opioid analgesic within the previous 4 hours of time of enrollment in study

• Patients with parent or legal guardian not present to give informed consent for enrollment in study

• Non-English speaking patients and/or parent

• Patients with a contraindication for the administration of intranasal medication (nasal trauma, aberrant nasal anatomy)

• Patients with ocular injuries

• Patients with a known allergy to ketamine, fentanyl, and/or midazolam

• Pregnant females

• Patients with history of seizure disorders